Back to Top Skip to main content Skip to sub-navigation

Defending the Homeland: NMRTC Bremerton ensures Operational Readiness and a Medically Ready Force

Image of Three healthcare workers wearing masks. Rear Adm. Blake L. Converse, Commander, Submarine Force, U.S. Pacific Fleet, recently contacted Capt. Shannon J. Johnson, Commanding Officer, Navy Medicine Readiness and Training Command (NMRTC) Bremerton, on behalf of his submariners, thanking her command’s leadership and Sailors for their support to the Pacific Submarine Force during the COVID-19 pandemic outbreak. (Official Navy photo by Douglas H Stutz, NMRTC Bremerton public affairs officer)

Recommended Content:

Coronavirus | Health Readiness

‘Swabbie’ might be older generational slang for a Sailor, but current Navy Medicine swab testing support for the Fleet has been timely, as well as progressive.

Navy Rear Adm. Blake Converse, commander, Submarine Force, U.S. Pacific Fleet, recently contacted Navy Capt. Shannon Johnson, commanding officer, Navy Medicine Readiness and Training Command Bremerton, on behalf of his submariners, thanking her command’s leadership and Sailors for their support to the Pacific Submarine Force during the COVID-19 pandemic outbreak.

“Through these uncertain times, your team took care of my Sailors in a disciplined yet compassionate manner,” wrote Converse. “It is clear that NMRTC Bremerton has every Sailor in their best interest. Your efforts contribute to the submarine force’s mission readiness.”

Supporting mission readiness has long been a responsibility for the ready medical force of NMRTC Bremerton, ensuring that Navy ship, squadron, shore and submarine personnel are collectively a medically ready force and operationally fit to perform and deploy when called upon.

According to Navy Cmdr. Robert Uniszkiewicz, NHB/NMRTC Bremerton COVID-19 lead and Public Health Emergency Officer, the effectiveness of  the swab testing for the submarine fleet homeported in the Pacific Northwest is a direct extension of the protective measures implemented at all commands to help curtail the spread of COVID-19.

Image of Hannah Carlson wearing a mask
Navy Hospital Corpsman 1st Class Hannah Carlson, assigned to Naval Hospital Bremerton's Urgent Care Clinic, oversees daily clinical duties during the command's ongoing effort to help stop the spread of COVID-19. Carlson's efforts the past months have her highly regarded as the linchpin for the UCC.  (Official Navy photo by Douglas H Stutz, NHB/NMRTC Bremerton public affairs officer)

“Testing is not as important as physical distancing, wearing facial coverings and proper hygiene practices, explained Uniszkiewicz. “However, with these measures in place, large scale surveillance testing has provided another layer of confidence that our units preparing to deploy are both ready and safe to do so.”

The swab testing itself is unique simply because having a foreign object inserted into the nasal passage is not a common experience. The hospital corpsman inserts the swab – similar to a longer version of a Q-tip – deep into a person’s nose where it is whirled around for several seconds to collect secretion sample necessary for testing.

Taking the sample is just the initial step. Uniszkiewicz noted that NMRTC Bremerton has not been alone in the task of ensuring units are ready to deploy. It’s been a team-effort across the board with a number of support layers in place.

“Our testing efforts would not be possible without the collaboration with Madigan Army Medical Center laboratory. Additionally, serviced commands are stepping up by conducting their own contact tracing for which our Preventive Medicine team has conducted training. For large scale testing, it has been a tri-service effort to meet the demands for supply, transport, and tracking in order to preserve (COVID-free) ‘bubbles’ around units before deployment, during deployment, and after deployment when they return,” explained Uniszkiewicz.

At NMRTC Bremerton, there are noticeable safeguards added, e.g., waiting room seating has been changed to be six feet apart and areas to stand are also marked six feet apart. Per Department of Defense directive, it is also mandatory for all staff, patients and visitors to wear either a facial covering or mask. Only one visitor is allowed per patient and frequent cleaning of ‘high touch’ areas is now standard procedure, even more so that in the past. Although non-urgent surgeries have resumed and face-to-face encounters have gradually increased, virtual appointments are continuing to be offered.

Screening and testing protocol is also in place for all those eligible for care at NMRTC Bremerton.

“Screening upon entry to the facility is an invaluable mitigation strategy to keep COVID-like illness out of the hospital proper and direct it toward our Urgent Care Center and tents.  This, along with universal use of facial coverings, reassures our patients, their families, and our staff that we are dedicated to keeping them as safe as possible within our facilities,” Uniszkiewicz said.

The screening process really begins prior to an appointment as patients are contacted for pre-screening checks. Once a person arrives at the command, there are staff directing traffic flow to guide them. They are directed through the screening process which begins with a series of questions. Depending on the replies, the patient will be directed to either a treatment tent or testing area, or given the ‘green light’ to enter the hospital following the protective measures in place.

Additionally, before entering the hospital or clinic, if a person does not have a facial covering, they will be provided one to wear at all times when in the hospital.

At NHB/NMRTC Bremerton and across the Navy, medical providers and staff are ensuring patients are properly cared for in the COVID-19 environment, while still maintaining operational readiness.

You also may be interested in...

20-004

Policy

Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

DHA-Policy Memorandum 21-004: Coronavirus Disease 2019 Vaccination Attestation, Screening Testing, and Vaccination Verification

Policy

This memorandum provides guidance on the implementation of vaccination, attestation, and testing requirements in accordance with the References listed in Attachment 1 to reduce the transmission of the virus that causes COVID-19.

6205.01

Policy

Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

3020.01, Change 2

Policy

Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

  • Identification #: 3020.01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

3020.01, Change 1

Policy

Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

  • Identification #: 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

Policy

The Defense Health Agency (DHA) Memorandum, based on the authority of References (a) and (b), and in accordance with the guidance of References (c) and (d), establishes the DHA’s procedures to standardize the coding for Coronavirus 2019 (COVID-19) Military Medical Treatment Facilities (MTFs). This memorandum cancels and replaces DHA- Policy Memorandum 20-003 of (13 April 2020). A change was issued since the cancelled Memorandum 20-003 of (13 April 2020), the Attachment titles were updated to reflect that Attachments 1, 2, and 4 are considered Policies as opposed to Guidance.

  • Identification #: 20-003
  • Date: 5/13/2020
  • Type: Memorandums
  • Topics: Coronavirus

6200.05

Policy

Force Health Protection Quality Assurance (FHPQA) Program

  • Identification #: 6200.05
  • Date: 5/2/2018
  • Type: DHA Procedural Instruction
  • Topics: Health Readiness

DoD Instruction 6200.05: Force Health Protection Quality Assurance (FHPQA) Program

Policy

This issuance establishes policy, assigns responsibilities, and defines requirements for the development and establishment of the FHPQA Program in accordance with the authority in DoD Directive (DoDD) 5124.02, Sections 731 and 738 of Public Law 108-375; Sections 1074f, 1092a, and 1073b of Title 10, United States Code; and DoDDs 6200.04 and 5136.13.

DoD Instruction 6490.13: Comprehensive Policy on Traumatic Brain Injury-Related Neurocognitive Assessments by the Military Services

Policy

This instruction establishes policy, assigns responsibilities, and prescribes standard elements, pursuant to section 722 of Public Law 111-383, requiring the implementation of a comprehensive neurocognitive assessment policy in the Military Services.

<< < 1 2 3 > >> 
Showing results 1 - 15 Page 1 of 3
Refine your search
Last Updated: July 22, 2020

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.